News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dallas Matthew D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/05/2019 |
4
| Dallas Matthew D (Director) has filed a Form 4 on Biostage, Inc.|
Txns:
| Granted 10,364 options to buy
@ $2.9, valued at
$30.1k
Granted 8,411 options to buy
@ $2.9, valued at
$24.4k
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2018 |
4
| Dallas Matthew D (Director) has filed a Form 4 on Biostage, Inc.|
Txns:
| Granted 10,897 options to buy
@ $2.75, valued at
$30k
|
|
| 11/15/2018 |
3
| Dallas Matthew D (Director) has filed a Form 3 on Biostage, Inc. |
| 02/02/2018 |
4
| Dallas Matthew D (CFO) has filed a Form 4 on AVEO PHARMACEUTICALS INC|
Txns:
| Granted 250,000 options to buy
@ $3.08, valued at
$770k
|
|
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/08/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2017 |
4
| Dallas Matthew D (CFO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Sold 1,473 shares
@ $36.25, valued at
$53.4k
|
|
| 12/01/2016 |
4
| Dallas Matthew D (CFO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Sold 1,473 shares
@ $35.1671, valued at
$51.8k
|
|
| 03/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|